Patents by Inventor Aurelien LORIN

Aurelien LORIN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INFLUENZA VIRUS HEMAGGLUTININ MUTANTS
    Publication number: 20210371472
    Abstract: The present invention relates to the production of modified influenza viral proteins in plants. More specifically, the present invention relates to producing and increasing influenza virus-like particle (VLP) production in plants, wherein the VLPs comprise the modified influenza viral proteins, such as modified influenza hemagglutinin (HA). The HA protein may comprising an amino acid sequence comprising at least one substitution when compared to a corresponding wildtype amino acid sequence. Further provided are nucleic acid encoding the modified HA protein. Furthermore methods of producing an influenza virus like particle (VLP) and methods of increasing yield of production of an influenza virus like particle (VLP) in a plant, portion of a plant, or a plant cell, are also provided.
    Type: Application
    Filed: June 27, 2019
    Publication date: December 2, 2021
    Inventors: Pierre-Olivier LAVOIE, Aurelien LORIN, Alain DOUCET, Marc-Andre D'AOUST, Manon COUTURE
  • INFLUENZA VIRUS HEMAGGLUTINIIN MUTANTS
    Publication number: 20210340184
    Abstract: The present invention relates to the production of modified influenza vial proteins in plants. More specifically, the present invention relates to producing and increasing influenza virus-like particle (VLP) production in plants, wherein the VLPs comprise the modified influenza viral proteins, such as modified influenza hemagglutinin (HA). The H A protein may comprising an amino acid sequence comprising at least one substitution when compared to a corresponding wildtype amino acid sequence. Further provided are nucleic acid encoding the modified H A protein. Furthermore methods of producing an influenza virus like particle (VLP) and methods of increasing yield of production of an influenza virus like particle (VLP) in a plant, portion of a plant, or a plant cell, are also provided.
    Type: Application
    Filed: June 27, 2019
    Publication date: November 4, 2021
    Inventors: Pierre-Olivier LAVOIE, Aurelien LORIN, Alain DOUCET, Marc-Andre D'AOUST, Manon COUTURE
  • INFLUENZA VIRUS HEMAGGLUTININ MUTANTS
    Publication number: 20210221853
    Abstract: The present invention relates to the production of modified influenza viral proteins in plants. More specifically, the present invention relates to producing and increasing influenza virus-like particle (VLP) production in plants, wherein the VLPs comprise the modified influenza viral proteins, such as modified influenza hemagglutinin (HA). The HA protein may comprising an amino acid sequence comprising at least one substitution when compared to a corresponding wildtype amino acid sequence. Further provided are nucleic acid encoding the modified HA protein. Furthermore methods of producing an influenza virus like particle (VLP) and methods of increasing yield of production of an influenza virus like particle (VLP) in a plant, portion of a plant, or a plant cell, are also provided.
    Type: Application
    Filed: June 27, 2019
    Publication date: July 22, 2021
    Inventors: Pierre-Olivier LAVOIE, Aurelien LORIN, Alain DOUCET, Marc-Andre D'AOUST, Manon COUTURE